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120* Multiplex cytokine proﬁle detection in young children with cystic
ﬁbrosis
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Pulmonology, University Medical Centre Utrecht, Utrecht, Netherlands; 2Paediatric
Immunology, University Medical Centre Utrecht, Utrecht, Netherlands
In young cystic ﬁbrosis (CF) patients with mild lung disease it is unclear whether
signs of a systemic inﬂammatory response are present. We therefore measured
plasma cytokine proﬁles in young, clinically stable CF patients with mild lung
disease.
Twenty-eight different cytokines, chemokines and soluble adhesion molecules were
measured in 47 CF children, ages 1.7−12.2 years, using a multiplex immunoassay.
Sputum cultures were obtained on the same day as blood sampling and children
were categorized as uninfected (n = 12), positive for Staphylococcus aureus and/or
Haemophilus inﬂuenzae (n = 26) or positive for Pseudomonas aeruginosa (n = 9).
Data were compared to those obtained from 20 healthy control children, ages
3.8−11.5 years.
All CF children displayed a pro-inﬂammatory cytokine proﬁle and especially
interleukin (IL)-1a, IL-4, IL-12 and tumor necrosis factor-alpha (TNF-a) were sig-
niﬁcantly higher in CF children (p-values <0.001 or <0.05). Although interleukin-8
and oncostatin M (OSM) were also higher in CF children, CC-chemokines were
signiﬁcantly lower than in controls. In CF children bacterial sputum culture results
did not inﬂuence plasma cytokine proﬁles, except for soluble vascular endothelial
cell adhesion molecule-1 (sVCAM-1). sVCAM-1 concentrations were signiﬁcantly
lower in uninfected CF children compared to Pseudomonas aeruginosa positive
CF children (2186.8±1207.7 versus 7170.21±2129.7, p = 0.025).
Young, clinically stable CF children display a derangement of inﬂammatory me-
diator proﬁles. Pro-inﬂammatory cytokines are increased in plasma while CC-
chemokines are decreased.
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Objectives: Abnormal immunoglobulin (Ig) levels, particularly abnormal IgG
levels, have been described in cystic ﬁbrosis (CF) patients. The aim of the present
study was to assess Ig levels in our CF patients and relate these to parameters of
disease severity.
Methods: IgG, IgA, IgM levels were measured in 62 patients. Hyper- and hypo-IgG
were compared with age- and sex-matched control patients who had normal IgG
levels.
Results: Median age of patients was 15.1 years (0.9−46.6). Male/female ratio
was 1:1. Mean FEV1 was 68.1% and chronic Pseudomonas aeruginosa status
was 37.1%. Five patients had hypo-IgG (8.1%), all of them were males and
less than 18 years old. Eighteen patients had hyper-IgG (29.0%), were mainly
females (61.1%) and more than 18 years old (72.2%). No difference was found
in any parameters of severity between hypo-IgG and control patients. Hyper-IgG
patients younger than 18 years old had lower FEV1 (73.4% versus 45.6%, p< 0.04)
and worse Shwachman scores. Female patients had lower FEV1 (p< 0.05) and
FVC (p< 0.05) and higher levels of erythrocyte sedimentation rate (p< 0.05) and
neutrophils (p< 0.05).
Conclusions: From our study we conclude that (1) Hypo-IgG is present in some
young and male CF patient and does not seem to have consequences, (2) Hyper-IgG
is a marker of worse clinical status (already published) and (3) this seems to be
particularly true in children and thus total IgG levels may be a useful additional tool
for monitoring of pediatric CF patients, (4) Unfavourable role of age and female
gender in prognosis of the patients seems to be conﬁrmed and could be explained
by an increased inﬂammatory reaction.
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Cytokines regulation plays signiﬁcant role in creation of inﬂammatory process and,
ﬁrst of all, cytokines synthesized in inﬂammatory site. In this study we investigated
levels of pro-inﬂammatory cytokines IL-1b, TNFa and IL-8 in serum, sputum and
lavage ﬂuid (BALF) from 78 patients (mean age 11.85±0.82) with Cystic ﬁbrosis
(CF) at the exacerbation period of disease and at the minimum activity period of
inﬂammatory process.
It is revealed that level of IL-8 in sputum and BALF of patients with CF exceeds
the control values 30–100 times. This fact points out about local synthesize IL-8
predominance in inﬂammatory site. Il-1b and TNF a levels of patients with CF
was signiﬁcantly (p< 0.005) higher at exacerbation period of disease to compare
with minimum activity period of inﬂammatory process. The maximum value was
determined in sputum and BALF. These results predominance of local lung synthesis
of pro-inﬂammatory cytokines takes place in patients with CF.
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Background: Airway inﬂammation in CF is associated with marked remodelling
and bronchiectasis. Pro-inﬂammatory mediators such as advanced glycation end-
products (AGE) derived from carbohydrate in diet and its soluble receptor (sRAGE)
may perpetuate this response in the lung and other organs such as the kidney
(Westall et al, 2005).
Methods: Adults with CF (n = 58, 35 males, 86% pancreatic insufﬁcient, mean age
33.9±7.7 years, range 23 to 62 years, mean FEV1%predicted 58.7±22. (range 20–
110)) and 24 healthy adults (13 male, mean age 32.7±9.2 years, range 21−55 years)
were studied. CF participants provided 1−3 serum samples each over a six month
period. Serum was analysed for levels of advanced glycation end-product (AGE-
CML) and sRAGE by ELISA.
Results: Median (IQR) levels for AGE-CML were 1650 (1158, 1986) nmol/mmol
lysine in CF and 659 (464, 1015) nmol/mmol lysine in controls (p< 0.0001).
Median (IQR) levels for sRAGE were 1190 (946, 1578) ug/ml in CF and 975
(751, 1352) ug/ml in controls (NS). FEV1%predicted was negatively correlated
with sRAGE level in CF (rho = −0.45, p = 0.0005), but not with AGE-CML level
(rho = −0.09, p = 0.51). No other clinical factors analysed were signiﬁcantly corre-
lated with AGE-CML or sRAGE levels (age, gender, BMI, presence of diabetes or
HbA1c level).
Conclusions: The levels of sRAGE reﬂect ability to respond to this pathway and
are associated with poorer lung function. Modiﬁcation of diet in CF may reduce
this mediator and tissue injury.
